Zobrazeno 1 - 10
of 938
pro vyhledávání: '"Groningen T"'
Autor:
Westerhout EM; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands. e.m.westerhout@amsterdamumc.nl r.versteeg@amsterdamumc.nl., Hamdi M; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Stroeken P; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Nowakowska NE; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Lakeman A; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., van Arkel J; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Hasselt NE; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Bleijlevens B; Department of Medical Biochemistry, Amsterdam UMC, Amsterdam, the Netherlands., Akogul N; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Haneveld F; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Chan A; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., van Sluis P; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Zwijnenburg D; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Volckmann R; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., van Noesel CJM; Department of Pathology, Amsterdam UMC, Amsterdam, the Netherlands., Adameyko I; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.; Center for Brain Research, Medical University of Vienna, Vienna, Austria., van Groningen T; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Koster J; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Valentijn LJ; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., van Nes J; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Versteeg R; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands. e.m.westerhout@amsterdamumc.nl r.versteeg@amsterdamumc.nl.; Berlin Institute of Health (BIH), Berlin, Germany.
Publikováno v:
Cancer research [Cancer Res] 2022 Feb 01; Vol. 82 (3), pp. 484-496. Date of Electronic Publication: 2021 Dec 01.
Autor:
Sofie Mohlin, Peter Stroeken, van Nes J, Franciska Haneveld, Alvin Chan, Niklasson Cu, Daniel Bexell, van Sluis P, Nurdan Akogul, Jan Koster, Rogier Versteeg, Linda J. Valentijn, Frank Westermann, Nancy E. Hasselt, Selina Jansky, Ellen M. Westerhout, van Groningen T, Arjan Lakeman, von Stedingk K, Sven Påhlman, Caroline Wigerup, Danny A. Zwijnenburg, Mohamed Hamdi, Igor Adameyko
Neuroblastoma is a pediatric tumor of the adrenergic sympathetic lineage. Most high risk neuroblastoma go in complete clinical remission by chemotherapy, which is subsequently complemented by retinoic acid (RA) maintenance therapy. However, by unreso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9038fb701339c80be36df7f06f1394dd
https://doi.org/10.1101/2021.05.18.444639
https://doi.org/10.1101/2021.05.18.444639
Autor:
Kreuger IZM; Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands; Leiden Center for Computational Oncology, Leiden University Medical Center, Leiden, The Netherlands., Slieker RC; Leiden Center for Computational Oncology, Leiden University Medical Center, Leiden, The Netherlands; Department of Cell & Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands., van Groningen T; Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands; Leiden Center for Computational Oncology, Leiden University Medical Center, Leiden, The Netherlands., van Doorn R; Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands; Leiden Center for Computational Oncology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: rvandoorn@lumc.nl.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2023 Jan; Vol. 143 (1), pp. 18-25.e1. Date of Electronic Publication: 2022 Sep 16.
Autor:
de Bruin-Hoegée M; van 't Hoff Institute for Molecular Sciences, Faculty of Science, University of Amsterdam, P.O. Box 94157, Amsterdam 1090GD, The Netherlands.; TNO Defence, Safety and Security, Dep. CBRN Protection, Lange Kleiweg 137, Rijswijk 2288GJ, The Netherlands., van Damme IM; van 't Hoff Institute for Molecular Sciences, Faculty of Science, University of Amsterdam, P.O. Box 94157, Amsterdam 1090GD, The Netherlands., van Groningen T; TNO Defence, Safety and Security, Dep. CBRN Protection, Lange Kleiweg 137, Rijswijk 2288GJ, The Netherlands., van der Riet-van Oeveren D; TNO Defence, Safety and Security, Dep. CBRN Protection, Lange Kleiweg 137, Rijswijk 2288GJ, The Netherlands., Noort D; TNO Defence, Safety and Security, Dep. CBRN Protection, Lange Kleiweg 137, Rijswijk 2288GJ, The Netherlands., van Asten AC; van 't Hoff Institute for Molecular Sciences, Faculty of Science, University of Amsterdam, P.O. Box 94157, Amsterdam 1090GD, The Netherlands.; CLHC, Amsterdam Center for Forensic Science and Medicine, University of Amsterdam, P.O. Box 94157, Amsterdam 1090GD, The Netherlands.
Publikováno v:
Chemical research in toxicology [Chem Res Toxicol] 2022 Jun 20; Vol. 35 (6), pp. 1070-1079. Date of Electronic Publication: 2022 May 27.
Efficacy of atropine sulfate/obidoxime chloride co-formulation against sarin exposure in guinea pigs
Autor:
Joosen, M.J.A., Klaassen, S.D., Verheij, E., Groningen, T. van, Cornelissen, A.S., Skiadopoulos, M.H., Cochrane, L., Shearer, J.D.
Publikováno v:
Chemico-Biological Interactions, 296, 34-42
The efficacy and pharmacokinetics of the aqueous co-formulation contents of the Trobigard™ (atropine sulfate, obidoxime chloride) auto-injector were evaluated in a sarin exposed guinea pig model. Two subcutaneous (sc) sarin challenge doses were eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::dd8f3637ca7e86be44a8e27aac9f63d9
http://resolver.tudelft.nl/uuid:6af8956c-6b8d-41ff-9a76-365b47ba199f
http://resolver.tudelft.nl/uuid:6af8956c-6b8d-41ff-9a76-365b47ba199f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nakamura, Fumihiko1 (AUTHOR), Nakano, Yushi2 (AUTHOR), Yamada, Shiro3 (AUTHOR) dtailang21@gmail.com
Publikováno v:
Hereditas. 11/14/2024, Vol. 161 Issue 1, p1-17. 17p.
Autor:
Seneviratne, Janith A.1,2 (AUTHOR), Ravindrarajah, Daenikka1,2 (AUTHOR), Carter, Daniel R.1,3 (AUTHOR), Zhai, Vicki1 (AUTHOR), Lalwani, Amit1 (AUTHOR), Krishan, Sukriti1,2 (AUTHOR), Balachandran, Anushree1 (AUTHOR), Ng, Ernest1,2 (AUTHOR), Pandher, Ruby1,2 (AUTHOR), Wong, Matthew1,2 (AUTHOR), Nero, Tracy L.4 (AUTHOR), Wang, Shudong5 (AUTHOR), Norris, Murray D.1,2,6 (AUTHOR), Haber, Michelle1,2 (AUTHOR), Liu, Tao1,2 (AUTHOR), Parker, Michael W.4,7 (AUTHOR), Cheung, Belamy B.1,2 (AUTHOR) bcheung@ccia.unsw.edu.au, Marshall, Glenn M.1,2,8 (AUTHOR) glenn.marshall@health.nsw.gov.au
Publikováno v:
Cancer Medicine. Nov2024, Vol. 13 Issue 21, p1-20. 20p.
Autor:
Cheng, Bo1 (AUTHOR), Fang, Wanqi1,2 (AUTHOR), Pastor, Steven3,4,5 (AUTHOR), March, Alexander R.1 (AUTHOR), Porras, Tania1 (AUTHOR), Wu, Hong-Wei1 (AUTHOR), Velez, Miriam1 (AUTHOR), Parekh, Chintan1,2 (AUTHOR), Maris, John M.3,4,5 (AUTHOR), Asgharzadeh, Shahab1,2 (AUTHOR), Huang, Miller1,2 (AUTHOR) mhuang@chla.usc.edu
Publikováno v:
Scientific Reports. 10/4/2024, Vol. 14 Issue 1, p1-13. 13p.
Autor:
Kentrop J; TNO Defence, Safety & Security, CBRN Protection, Lange Kleiweg 137, NL-2288, GJ Rijswijk, the Netherlands., Savransky V; Emergent BioSolutions Inc, 300 Professional Drive, Gaithersburg, MD, 20879, USA., Klaassen SD; TNO Defence, Safety & Security, CBRN Protection, Lange Kleiweg 137, NL-2288, GJ Rijswijk, the Netherlands., van Groningen T; TNO Defence, Safety & Security, CBRN Protection, Lange Kleiweg 137, NL-2288, GJ Rijswijk, the Netherlands., Bohnert S; Defense Research and Development Canada - Suffield Research Centre, Casualty Management Section, PO Box 4000 Station Main, Medicine Hat, Alberta, T1A 8K6, Canada., Cornelissen AS; TNO Defence, Safety & Security, CBRN Protection, Lange Kleiweg 137, NL-2288, GJ Rijswijk, the Netherlands., Cochrane L; Emergent BioSolutions Inc, 300 Professional Drive, Gaithersburg, MD, 20879, USA., Barry J; Emergent BioSolutions Inc, 300 Professional Drive, Gaithersburg, MD, 20879, USA., Joosen MJA; TNO Defence, Safety & Security, CBRN Protection, Lange Kleiweg 137, NL-2288, GJ Rijswijk, the Netherlands. Electronic address: Marloes.joosen@tno.nl.
Publikováno v:
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2021 Feb; Vol. 119, pp. 104823. Date of Electronic Publication: 2020 Nov 16.